New Algorithm Aims to Streamline Type 2 Diabetes Care for Family Doctors
MADRID, SPAIN – A novel algorithm, DiabeTosMG 2025, has been launched to aid family doctors in the management of type 2 diabetes, offering a multifactorial and individualized approach to treatment. Developed with input from specialists, the tool prioritizes treatments demonstrating proven efficacy for cardiovascular, renal, and weight loss benefits, as recognized by organizations including the ADA/EASD (American Diabetes Association/european Association for the Study of Diabetes), AACE (Association of Clinical Endocrinology), and ESC (European Society of Cardiology).
The algorithm incorporates a star-rating system to guide treatment choices based on clinical benefit, especially for patients with comorbidities like chronic renal disease, heart failure, and established cardiovascular disease. Beyond pharmacological interventions, DiabeTosMG 2025 emphasizes practical recommendations for nutrition, physical exercise, and lifestyle modifications.
An integrated QR code provides professionals with direct access to downloadable materials for personalized prescriptions of diet and physical activity – a practice the Spanish government is now financing for therapeutic purposes. The resource also includes key recommendations for specific patient contexts, such as end-of-life care, liver disease, and extreme obesity, alongside medication adjustments aligned with the latest 2022 KDIGO guidelines for diabetes management in chronic kidney disease.
The initiative aims to provide a “swift and close reference tool” to a greater number of family doctors, integrating into their daily clinical routines as the first line of defense in diabetes diagnosis, monitoring, and treatment. Developers envision the algorithm bridging the gap between scientific evidence and real-world clinical practice, ultimately improving patient outcomes through more optimal and individualized care.
